{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:08:16Z","timestamp":1773299296189,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T00:00:00Z","timestamp":1272499200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s10620-010-1243-0","type":"journal-article","created":{"date-parts":[[2010,4,28]],"date-time":"2010-04-28T21:51:22Z","timestamp":1272491482000},"page":"1761-1769","source":"Crossref","is-referenced-by-count":30,"title":["Late Relapse of Type 1 Autoimmune Hepatitis After Corticosteroid Withdrawal"],"prefix":"10.1007","volume":"55","author":[{"given":"Albert J.","family":"Czaja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,29]]},"reference":[{"key":"1243_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM198101013040102","volume":"304","author":"AJ Czaja","year":"1981","unstructured":"Czaja AJ, Ludwig J, Baggenstoss AH, Wolf A. Corticosteroid-treated chronic active hepatitis in remission: Uncertain prognosis of chronic persistent hepatitis. N Engl J Med. 1981;304:5\u20139.","journal-title":"N Engl J Med"},{"key":"1243_CR2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.1840030510","volume":"3","author":"JE Hegarty","year":"1983","unstructured":"Hegarty JE, Nouri Aria KT, Portmann B, Eddleston AL, Williams R. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology. 1983;3:685\u2013689.","journal-title":"Hepatology"},{"key":"1243_CR3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.1840040409","volume":"4","author":"AJ Czaja","year":"1984","unstructured":"Czaja AJ, Davis GL, Ludwig J, Taswell HF. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis. Hepatology. 1984;4:622\u2013627.","journal-title":"Hepatology"},{"key":"1243_CR4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/jhep.2002.32485","volume":"35","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Menon KV, Carpenter HA. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: A retrospective analysis. Hepatology. 2002;35:890\u2013897.","journal-title":"Hepatology"},{"key":"1243_CR5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0016-5085(87)90862-6","volume":"92","author":"AJ Czaja","year":"1987","unstructured":"Czaja AJ, Beaver SJ, Shiels MT. Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis. Gastroenterology. 1987;92:215\u2013219.","journal-title":"Gastroenterology"},{"key":"1243_CR6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1478-3231.2007.01444.x","volume":"27","author":"AJ Montano-Loza","year":"2007","unstructured":"Montano-Loza AJ, Carpenter HA, Czaja AJ. Consequences of treatment withdrawal in type 1 autoimmune hepatitis. Liver Int. 2007;27:507\u2013515.","journal-title":"Liver Int"},{"key":"1243_CR7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","volume":"36","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Freese DK. Practice guidelines of the American Association for the Study of Liver Diseases. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479\u2013497.","journal-title":"Hepatology"},{"key":"1243_CR8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/egh.09.15","volume":"3","author":"AJ Czaja","year":"2009","unstructured":"Czaja AJ. Current and future treatments of autoimmune hepatitis. Expert Rev Gastroenterol Hepatol. 2009;3:269\u2013291.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1243_CR9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1600-0676.2003.00810.x","volume":"23","author":"AJ Czaja","year":"2003","unstructured":"Czaja AJ, Carpenter HA. Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis. Liver Int. 2003;23:116\u2013123.","journal-title":"Liver Int"},{"key":"1243_CR10","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2004.30457.x","volume":"99","author":"S Verma","year":"2004","unstructured":"Verma S, Gunuwan B, Mendler M, Govindrajan S, Redeker A. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: Role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Am J Gastroenterol. 2004;99:1510\u20131516.","journal-title":"Am J Gastroenterol"},{"key":"1243_CR11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jhep.2005.06.006","volume":"43","author":"Y Miyake","year":"2005","unstructured":"Miyake Y, Iwasaki Y, Terada R, et al. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis. J Hepatol. 2005;43:951\u2013957.","journal-title":"J Hepatol"},{"key":"1243_CR12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1572-0241.2007.01153.x","volume":"102","author":"AJ Montano-Loza","year":"2007","unstructured":"Montano-Loza AJ, Carpenter HA, Czaja AJ. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse. Am J Gastroenterol. 2007;102:1005\u20131012.","journal-title":"Am J Gastroenterol"},{"key":"1243_CR13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929\u2013938.","journal-title":"J Hepatol"},{"key":"1243_CR14","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1023\/A:1018809431189","volume":"42","author":"AJ Czaja","year":"1997","unstructured":"Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig Dis Sci. 1997;42:1688\u20131696.","journal-title":"Dig Dis Sci"},{"key":"1243_CR15","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/hep.510240515","volume":"24","author":"AJ Czaja","year":"1996","unstructured":"Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology. 1996;24:1068\u20131073.","journal-title":"Hepatology"},{"key":"1243_CR16","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/0016-5085(92)91518-9","volume":"103","author":"AJ Czaja","year":"1992","unstructured":"Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver\/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology. 1992;103:1290\u20131295.","journal-title":"Gastroenterology"},{"key":"1243_CR17","first-page":"1206","volume":"90","author":"AJ Czaja","year":"1995","unstructured":"Czaja AJ, Manns MP. The validity and importance of subtypes in autoimmune hepatitis: A point of view. Am J Gastroenterol. 1995;90:1206\u20131211.","journal-title":"Am J Gastroenterol"},{"key":"1243_CR18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","volume":"16","author":"WH Summerskill","year":"1975","unstructured":"Summerskill WH, Korman MG, Ammon HV, Baggenstoss AH. Prednisone for chronic active liver disease: Dose titration, standard dose, and combination with azathioprine compared. Gut. 1975;16:876\u2013883.","journal-title":"Gut"},{"key":"1243_CR19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","volume":"63","author":"RD Soloway","year":"1972","unstructured":"Soloway RD, Summerskill WH, Baggenstoss AH, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: A controlled study of treatments and early prognosis. Gastroenterology. 1972;63:820\u2013833.","journal-title":"Gastroenterology"},{"key":"1243_CR20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0016-5085(81)90126-8","volume":"80","author":"AJ Czaja","year":"1981","unstructured":"Czaja AJ, Wolf AM, Baggenstoss AH. Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: Correlation of serum transaminase and gamma globulin levels with histologic features. Gastroenterology. 1981;80:687\u2013692.","journal-title":"Gastroenterology"},{"key":"1243_CR21","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","volume":"110","author":"SK Roberts","year":"1996","unstructured":"Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology. 1996;110:848\u2013857.","journal-title":"Gastroenterology"},{"key":"1243_CR22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jhep.2004.01.009","volume":"40","author":"AJ Czaja","year":"2004","unstructured":"Czaja AJ, Carpenter HA. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol. 2004;40:646\u2013652.","journal-title":"J Hepatol"},{"key":"1243_CR23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0016-5085(80)90866-5","volume":"78","author":"AJ Czaja","year":"1980","unstructured":"Czaja AJ, Ammon HV, Summerskill WH. Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission. Gastroenterology. 1980;78:518\u2013523.","journal-title":"Gastroenterology"},{"key":"1243_CR24","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/0016-5085(93)91081-R","volume":"105","author":"AJ Czaja","year":"1993","unstructured":"Czaja AJ, Carpenter HA. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology. 1993;105:1824\u20131832.","journal-title":"Gastroenterology"},{"key":"1243_CR25","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/BF02235164","volume":"16","author":"RD Soloway","year":"1971","unstructured":"Soloway RD, Baggenstoss AH, Schoenfield LJ, Summerskill WH. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis. 1971;16:1082\u20131086.","journal-title":"Am J Dig Dis"},{"key":"1243_CR26","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1089-3261(02)00028-4","volume":"6","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ. Treatment strategies in autoimmune hepatitis. Clin Liver Dis. 2002;6:799\u2013824.","journal-title":"Clin Liver Dis"},{"key":"1243_CR27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02093820","volume":"41","author":"A Czaja","year":"1996","unstructured":"Czaja A, Carpenter HA. Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci. 1996;41:305\u2013314.","journal-title":"Dig Dis Sci"},{"key":"1243_CR28","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","volume":"48","author":"AJ Czaja","year":"2008","unstructured":"Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology. 2008;48:1540\u20131548.","journal-title":"Hepatology"},{"key":"1243_CR29","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.21787","volume":"46","author":"AJ Montano-Loza","year":"2007","unstructured":"Montano-Loza AJ, Carpenter HA, Czaja AJ. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology. 2007;46:1138\u20131145.","journal-title":"Hepatology"},{"key":"1243_CR30","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","volume":"105","author":"AJ Czaja","year":"1993","unstructured":"Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology. 1993;105:1502\u20131507.","journal-title":"Gastroenterology"},{"key":"1243_CR31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","volume":"25","author":"AJ Czaja","year":"1997","unstructured":"Czaja AJ, Strettell MD, Thomson LJ, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology. 1997;25:317\u2013323.","journal-title":"Hepatology"},{"key":"1243_CR32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0676.1994.tb00067.x","volume":"14","author":"HF Lohr","year":"1994","unstructured":"Lohr HF, Schlaak JF, Gerken G, et al. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver. 1994;14:161\u2013166.","journal-title":"Liver"},{"key":"1243_CR33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0016-5085(99)70458-0","volume":"117","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ, Cookson S, Constantini PK, et al. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology. 1999;117:645\u2013652.","journal-title":"Gastroenterology"},{"key":"1243_CR34","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1023\/A:1005506031717","volume":"45","author":"AJ Czaja","year":"2000","unstructured":"Czaja AJ, Sievers C, Zein NN. Nature and behavior of serum cytokines in type 1 autoimmune hepatitis. Dig Dis Sci. 2000;45:1028\u20131035.","journal-title":"Dig Dis Sci"},{"key":"1243_CR35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","volume":"25","author":"MS Longhi","year":"2005","unstructured":"Longhi MS, Ma Y, Mitry RR, et al. Effect of CD4\u00a0+\u00a0CD25\u00a0+\u00a0regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun. 2005;25:63\u201371.","journal-title":"J Autoimmun"},{"key":"1243_CR36","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","volume":"176","author":"MS Longhi","year":"2006","unstructured":"Longhi MS, Hussain MJ, Mitry RR, et al. Functional study of CD4\u00a0+\u00a0CD25\u00a0+\u00a0regulatory T cells in health and autoimmune hepatitis. J Immunol. 2006;176:4484\u20134491.","journal-title":"J Immunol"},{"key":"1243_CR37","doi-asserted-by":"crossref","unstructured":"Czaja AJ. Features and consequences of untreated type 1 autoimmune hepatitis. Liver Int. 2009;29:816\u2013823.","DOI":"10.1111\/j.1478-3231.2008.01904.x"},{"key":"1243_CR38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00004836-198710000-00010","volume":"9","author":"BA Runyon","year":"1987","unstructured":"Runyon BA. Exquisite sensitivity to small decrements in corticosteroid dose in autoimmune chronic active hepatitis. J Clin Gastroenterol. 1987;9:541\u2013542.","journal-title":"J Clin Gastroenterol"},{"key":"1243_CR39","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hep.1840110621","volume":"11","author":"AJ Czaja","year":"1990","unstructured":"Czaja AJ. Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis. Hepatology. 1990;11:1044\u20131049.","journal-title":"Hepatology"},{"key":"1243_CR40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0952-7915(93)90065-Z","volume":"5","author":"J Sprent","year":"1993","unstructured":"Sprent J. Lifespans of naive, memory and effector lymphocytes. Curr Opin Immunol. 1993;5:433\u2013438.","journal-title":"Curr Opin Immunol"},{"key":"1243_CR41","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1073\/pnas.92.9.3707","volume":"92","author":"AR McLean","year":"1995","unstructured":"McLean AR, Michie CA. In vivo estimates of division and death rates of human T lymphocytes. Proc Natl Acad Sci USA. 1995;92:3707\u20133711.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1243_CR42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0165-2478(98)00037-6","volume":"62","author":"S Umeki","year":"1998","unstructured":"Umeki S, Kusunoki Y, Cologne JB, et al. Lifespan of human memory T-cells in the absence of T-cell receptor expression. Immunol Lett. 1998;62:99\u2013104.","journal-title":"Immunol Lett"},{"key":"1243_CR43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/336070a0","volume":"336","author":"D Gray","year":"1988","unstructured":"Gray D, Skarvall H. B-cell memory is short-lived in the absence of antigen. Nature. 1988;336:70\u201373.","journal-title":"Nature"},{"key":"1243_CR44","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.4049\/jimmunol.176.7.4051","volume":"176","author":"JS Obhrai","year":"2006","unstructured":"Obhrai JS, Oberbarnscheidt MH, Hand TW, et al. Effector T cell differentiation and memory T cell maintenance outside secondary lymphoid organs. J Immunol. 2006;176:4051\u20134058.","journal-title":"J Immunol"},{"key":"1243_CR45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.it.2008.06.002","volume":"29","author":"EB Bell","year":"2008","unstructured":"Bell EB, Westermann J. CD4 memory T cells on trial: immunological memory without a memory T cell. Trends Immunol. 2008;29:405\u2013411.","journal-title":"Trends Immunol"},{"key":"1243_CR46","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/art.1780391212","volume":"39","author":"E Ciruelo","year":"1996","unstructured":"Ciruelo E, de la Cruz J, Lopez I, Gomez-Reino JJ. Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide. Arthritis Rheum. 1996;39:2028\u20132034.","journal-title":"Arthritis Rheum"},{"key":"1243_CR47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/135245850100700210","volume":"7","author":"F Bethoux","year":"2001","unstructured":"Bethoux F, Miller DM, Kinkel RP. Recovery following acute exacerbations of multiple sclerosis: From impairment to quality of life. Mult Scler. 2001;7:137\u2013142.","journal-title":"Mult Scler"},{"key":"1243_CR48","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/lt.21809","volume":"15","author":"AJ Czaja","year":"2009","unstructured":"Czaja AJ. Recurrent autoimmune hepatitis after liver transplantation: A disease continuum or a fresh start? Liver Transpl. 2009;15:1169\u20131171.","journal-title":"Liver Transpl"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1243-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-010-1243-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1243-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:42:58Z","timestamp":1559245378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-010-1243-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,29]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["1243"],"URL":"https:\/\/doi.org\/10.1007\/s10620-010-1243-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,29]]}}}